Search Results - "Gailhajenet, A"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results by Moreno–Grau, Sonia, Rodríguez-Gómez, Octavio, Sanabria, Ángela, Pérez-Cordón, Alba, Sánchez-Ruiz, Domingo, Abdelnour, Carla, Valero, Sergi, Hernández, Isabel, Rosende-Roca, Maitée, Mauleón, Ana, Vargas, Liliana, Lafuente, Asunción, Gil, Silvia, Santos-Santos, Miguel Ángel, Alegret, Montserrat, Espinosa, Ana, Ortega, Gemma, Guitart, Marina, Gailhajanet, Anna, de Rojas, Itziar, Sotolongo-Grau, Óscar, Ruiz, Susana, Aguilera, Nuria, Papasey, Judith, Martín, Elvira, Peleja, Esther, Lomeña, Francisco, Campos, Francisco, Vivas, Assumpta, Gómez-Chiari, Marta, Tejero, Miguel Ángel, Giménez, Joan, Serrano-Ríos, Manuel, Orellana, Adelina, Tárraga, Lluís, Ruiz, Agustín, Boada, Mercè, Abdelnour, C., Aguilera, N., Alegret, M., Berthier, M., Boada, M., Buendia, M., Bullich, S., Campos, F., Cañabate, P., Cuevas, C., de Rojas, I., Espinosa, A., Gailhajenet, A., Diego, S., Gil, S., Giménez, J., Gismondi, R., Gómez-Chiari, M., Guitart, M., Hernández-Olasagarre, B., Hernández, I., Ibarria, M., Lafuente, A., Lomeña, F., Martín, E., Martínez, J., Mauleón, A., Monté, G., Moreno, M., Moreno-Grau, S., Núñez, L., Orellana, A., Ortega, G., Páez, A., Pancho, A., Pavía, J., Pelejà, E., Pérez-Cordon, A., Pérez-Grijalba, V., Pesini, P., Preckler, S., Rodríguez-Gómez, O., Romero, J., Rosende-Roca, M., Ruiz, A., Ruiz, S., Sanabria, A., Sánchez-Ruiz, D., Santos-Santos, M.A., Sarasa, M., Sotolongo-Grau, O., Tárraga, L., Tejero, M.A., Torres, M., Valero, S., Vargas, L., Vivas, A.

    Published in Alzheimer's & dementia (01-05-2018)
    “…Subjective cognitive decline (SCD) has been proposed as a potential preclinical stage of Alzheimer's disease (AD). Nevertheless, the genetic and biomarker…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Clinical performance of an antibody-free assay for plasma A[beta]42/A[beta]40 to detect early alterations of Alzheimer's disease in individuals with subjective cognitive decline by Pascual-Lucas, María, Allué, José Antonio, Sarasa, Leticia, Fandos, Noelia, Castillo, Sergio, Terencio, Jose, Sarasa, Manuel, Tartari, Juan Pablo, Sanabria, Ãngela, Tárraga, Lluís, Ruíz, Agustín, Marquié, Marta, Seo, Sang Won, Jang, Hyemin, Boada, Mercè, Aguilera, N, Alarcón-Martín, E, Alegret, M, Alonso-Lana, S, Berthier, M, Bojayrin, U, Buendia, M, Bullich, S, Campos, F, Cano, A, Caéabate, P, Caéada, L, Cuevas, C, de Rojas, I, Diego, S, Espinosa, A, Esteban-De Antonio, E, Gailhajenet, A, García-Sánchez, A, García, P, Giménez, J, Gómez-Chiari, M, Guitart, M, Hernández, I, Ibarria, M, Lafuente, A, Lleonart, N, Lomeéa, F, Martín, E, Moreno, M, Morera, A, Montrreal, L, Muéoz, N, Narvaiza, L, Niéerola, A, Nogales, A. B, Núéez, L, Orellana, A, Ortega, G, Páez, A, Pancho, A, Pelejà, E, Pérez, E, Pérez-Cordon, A, Perissinotti, A, Preckler, S, Pytel, V, Ricciardi, M, Rodríguez-Gomez, O, Roé-Vellvé, N, Ramis, M. I, Rosende-Roca, M, Seguer, S, Sotolongo-Grau, O, Stephens, A, Tejero, M. A, Torres, M, Valero, S, Vargas, L, Vivas, A

    Published in Alzheimer's research & therapy (05-01-2023)
    “…Background Accessible and cost-effective diagnostic tools are urgently needed to accurately quantify blood biomarkers to support early diagnosis of Alzheimer's…”
    Get full text
    Journal Article
  6. 6
  7. 7